Cegedim S.A.

PA:CGM France Health Information Services
Market Cap
$147.02 Million
€143.23 Million EUR
Market Cap Rank
#20701 Global
#155 in France
Share Price
€10.40
Change (1 day)
-1.89%
52-Week Range
€10.25 - €13.35
All Time High
€41.59
About

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments. The Health Insurance, HR and E-Services segment markets various products and services to insurance comp… Read more

Cegedim S.A. (CGM) - Net Assets

Latest net assets as of December 2024: €282.50 Million EUR

Based on the latest financial reports, Cegedim S.A. (CGM) has net assets worth €282.50 Million EUR as of December 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€986.89 Million) and total liabilities (€704.39 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €282.50 Million
% of Total Assets 28.63%
Annual Growth Rate 4.32%
5-Year Change 35.88%
10-Year Change 23.83%
Growth Volatility 26.38

Cegedim S.A. - Net Assets Trend (2002–2024)

This chart illustrates how Cegedim S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Cegedim S.A. (2002–2024)

The table below shows the annual net assets of Cegedim S.A. from 2002 to 2024.

Year Net Assets Change
2024-12-31 €282.50 Million -4.09%
2023-12-31 €294.56 Million -3.15%
2022-12-31 €304.13 Million +30.87%
2021-12-31 €232.39 Million +11.78%
2020-12-31 €207.90 Million +3.31%
2019-12-31 €201.25 Million +1.15%
2018-12-31 €198.96 Million +0.82%
2017-12-31 €197.35 Million +4.45%
2016-12-31 €188.94 Million -17.18%
2015-12-31 €228.13 Million +4.62%
2014-12-31 €218.06 Million -36.94%
2013-12-31 €345.82 Million -18.68%
2012-12-31 €425.26 Million -17.62%
2011-12-31 €516.23 Million +7.48%
2010-12-31 €480.31 Million +3.07%
2009-12-31 €465.99 Million +92.52%
2008-12-31 €242.05 Million +16.40%
2007-12-31 €207.94 Million -5.70%
2006-12-31 €220.51 Million +56.65%
2005-12-31 €140.77 Million -9.92%
2004-12-31 €156.26 Million +21.30%
2003-12-31 €128.82 Million +15.74%
2002-12-31 €111.29 Million --

Equity Component Analysis

This analysis shows how different components contribute to Cegedim S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1483.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings €254.02 Million 96.09%
Common Stock €13.43 Million 5.08%
Other Comprehensive Income €250.92 Million 94.92%
Total Equity €264.35 Million 100.00%

Cegedim S.A. Competitors by Market Cap

The table below lists competitors of Cegedim S.A. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cegedim S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 276,175,000 to 264,348,000, a change of -11,827,000 (-4.3%).
  • Net loss of 14,708,000 reduced equity.
  • New share issuances of 985,000 increased equity.
  • Other comprehensive income decreased equity by 11,922,000.
  • Other factors increased equity by 13,818,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-14.71 Million -5.56%
Share Issuances €985.00K +0.37%
Other Comprehensive Income €-11.92 Million -4.51%
Other Changes €13.82 Million +5.23%
Total Change €- -4.28%

Book Value vs Market Value Analysis

This analysis compares Cegedim S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.54x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.04x to 0.54x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 €10.01 €10.40 x
2003-12-31 €11.15 €10.40 x
2004-12-31 €14.17 €10.40 x
2005-12-31 €12.95 €10.40 x
2006-12-31 €20.10 €10.40 x
2007-12-31 €18.91 €10.40 x
2008-12-31 €25.84 €10.40 x
2009-12-31 €49.08 €10.40 x
2010-12-31 €34.36 €10.40 x
2011-12-31 €36.41 €10.40 x
2012-12-31 €30.42 €10.40 x
2013-12-31 €24.77 €10.40 x
2014-12-31 €15.61 €10.40 x
2015-12-31 €16.34 €10.40 x
2016-12-31 €13.53 €10.40 x
2017-12-31 €14.12 €10.40 x
2018-12-31 €14.28 €10.40 x
2019-12-31 €14.51 €10.40 x
2020-12-31 €15.02 €10.40 x
2021-12-31 €16.84 €10.40 x
2022-12-31 €20.88 €10.40 x
2023-12-31 €20.29 €10.40 x
2024-12-31 €19.30 €10.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cegedim S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -5.56%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2.25%
  • • Asset Turnover: 0.66x
  • • Equity Multiplier: 3.73x
  • Recent ROE (-5.56%) is below the historical average (1.66%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 14.66% 4.72% 1.14x 2.73x €5.10 Million
2003 15.19% 4.76% 1.11x 2.88x €6.33 Million
2004 22.16% 7.85% 0.96x 2.93x €18.71 Million
2005 9.33% 14.38% 0.26x 2.45x €-941.96K
2006 17.67% 7.14% 0.87x 2.83x €16.78 Million
2007 21.21% 5.82% 0.60x 6.05x €23.17 Million
2008 13.96% 3.97% 0.65x 5.38x €9.55 Million
2009 11.76% 6.26% 0.66x 2.86x €8.19 Million
2010 -3.49% -1.81% 0.67x 2.87x €-64.74 Million
2011 6.32% 3.57% 0.65x 2.70x €-18.99 Million
2012 -20.09% -9.26% 0.72x 3.03x €-127.83 Million
2013 -16.97% -6.50% 0.74x 3.54x €-93.18 Million
2014 -91.66% -40.48% 0.43x 5.27x €-221.55 Million
2015 29.36% 15.71% 0.49x 3.79x €44.15 Million
2016 -14.16% -6.07% 0.62x 3.75x €-45.64 Million
2017 5.65% 2.44% 0.61x 3.78x €-8.59 Million
2018 2.90% 1.23% 0.72x 3.26x €-14.11 Million
2019 1.34% 0.54% 0.62x 4.02x €-17.41 Million
2020 5.22% 2.18% 0.55x 4.36x €-9.93 Million
2021 11.30% 5.00% 0.66x 3.44x €3.02 Million
2022 4.78% 2.45% 0.62x 3.12x €-14.89 Million
2023 -2.68% -1.20% 0.67x 3.35x €-35.02 Million
2024 -5.56% -2.25% 0.66x 3.73x €-41.14 Million

Industry Comparison

This section compares Cegedim S.A.'s net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $12,902,623
  • Average return on equity (ROE) among peers: -69.90%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Cegedim S.A. (CGM) €282.50 Million 14.66% 2.49x $55.75 Million
AbL Diagnostics SA (ABLD) $7.09 Million -0.80% 0.02x $401.58K
AMA Corp PLC (ALAMA) $26.90 Million -36.57% 0.42x $2.09 Million
Intrasense (ALINS) $1.65 Million -341.90% 3.65x $4.69 Million
SMAIO SA (ALSMA) $1.79 Million -94.52% 1.15x $7.78 Million
Equasens S. A. (EQS) $38.61 Million 23.58% 1.03x $174.86 Million
Media Lab SpA (MLLAB) $1.37 Million 30.81% 0.42x $31.45K